tiprankstipranks
Trending News
More News >
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market

Alaunos Therapeutics (TCRT) Income Statement

Compare
695 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q3 2025), Alaunos Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Alaunos Therapeutics's net income was $-1.16M. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.00K$ 5.00K$ 2.92M$ 398.00K$ 0.00
Gross Profit
$ 10.00K$ -4.80M$ 2.92M$ 398.00K$ -1.13M
Operating Expenses
$ 4.82M$ 29.47M$ 38.03M$ 77.95M$ 79.23M
Depreciation and Amortization
$ 2.00K$ 2.31M$ 2.76M$ 2.60M$ 1.13M
EBITDA
$ -4.68M$ -30.90M$ -31.82M$ -74.97M$ -78.85M
Operating Income
$ -4.81M$ -34.27M$ -35.10M$ -77.55M$ -80.36M
Other Income/Expenses
$ 133.00K$ -873.00K$ -2.63M$ -1.20M$ 385.00K
Pretax Income
$ -4.68M$ -35.14M$ -37.73M$ -78.75M$ -79.98M
Net Income
$ -4.68M$ -35.14M$ -37.73M$ -78.75M$ -79.98M
Per Share Metrics
Basic EPS
$ -2.92$ -21.97$ -25.97$ -53.80$ -56.42
Diluted EPS
$ -2.92$ -21.97$ -25.97$ -53.80$ -56.42
Weighted Average Shares Outstanding
1.60M 1.60M 1.45M 1.43M 1.40M
Weighted Average Shares Outstanding (Diluted)
1.60M 1.60M 1.45M 1.43M 1.40M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History